Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. - Wikidata - awgldk - TriplyDB

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

http://www.wikidata.org/entity/Q30887474

about

Tumor angiogenesis: pericytes and maturation are not to be ignored Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Role of hypoxia-inducible factors in breast cancer metastasis Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis Minimal residual disease and circulating tumor cells in breast cancer Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway FBP1 expression is associated with basal-like breast carcinoma Therapeutic effects of matrine on primary and metastatic breast cancer.Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism.Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular-signal-regulated kinase and DNA in circulating tumor cells.Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling Single circulating tumor cell profiling: a new perspective for targeted therapy?Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients.Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells.TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer Clinical relevance and biology of circulating tumor cells.Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition.Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer.Circulating cancer cells.Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.Circulating tumor cells as emerging tumor biomarkers in breast cancer.Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment.Plasticity of disseminating cancer cells in patients with epithelial malignancies.Molecular analysis of circulating tumour cells-biology and biomarkers.Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment.Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.More precise prediction in Chinese patients with penile squamous cell carcinoma: protein kinase CK2α catalytic subunit (CK2α) as a poor prognosticator.Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells.The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis.What's new on circulating tumor cells? A meeting report.Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications.

P2860

Q21296683-5BD6E0CC-55C4-4133-8902-D884F5DF15F4 Q26748850-4CC2E89E-0B3B-41E5-AB5E-02AE2F9AFAA8 Q26860122-68F79DEB-1C02-4EAB-A3FD-0414AC43A6DF Q26866144-19DB5DA6-7865-4D46-A486-502658E3D5FF Q27010152-7D8DA4AD-DADF-4670-A1DE-B0BC46DC6FEC Q28085029-59099597-7A5F-463A-A4A5-E097F3BCF518 Q28831292-777FD5A0-B9AB-4DDF-80AB-800D3921DD93 Q33686009-C4C2F4AD-3BA8-4D49-9C54-19A539831FF6 Q33742371-7C0D5333-FD27-4BAE-88F9-E982D4AAAD73 Q33868284-44E8A1A4-B498-4A83-96E0-A655712DF09F Q33887570-C866472F-6AFB-4743-BFF9-BB243BFF2D8C Q34038793-DE5E3B02-F9E4-452A-9621-B95E60C484AD Q34168398-883581A1-419F-4F7C-A2F1-D2BB306C21C7 Q34231456-C3F537C1-1CF6-40F6-BB92-E5AE157FEE3F Q34309316-91CB2C8B-F30C-4DE6-8450-D0E7CBBCE2A1 Q34468264-C005CD5D-1C66-478B-BBD0-036DDEA5EED4 Q34590296-A87D3C8F-451D-4277-B6FD-953E3FFC3EB3 Q35558093-216A9517-B204-4986-9DCF-80934D130D2F Q35592095-9CFE07E2-D750-4F21-8EF9-E190BDDB9764 Q35828584-69A1CCBD-A199-4AE6-BD06-F967454EFF41 Q35889548-1E050B6D-43C7-451F-BB6F-EC0CA815F104 Q36736295-156F6812-69B3-4189-89F3-5E0384ACC6F8 Q37405531-9B1852EB-C01D-4DD4-B804-0694E8323F5F Q37458674-6D13A34B-8571-4615-AC54-8CA8C94651BA Q37799957-75BA5DE5-97F9-4C3E-9B1A-BB9344F1DEF7 Q37890969-A3A23373-D0C8-4ECB-B566-42316322D2DD Q37898107-BBB0452F-16F0-4700-B0BA-834571D72CD4 Q37908134-C8A17B2A-74DF-430D-8B6F-2518BB1438FE Q38018253-A759A194-42B3-49FB-A8FC-9AD36BA0E1D2 Q38021683-73A2FD9E-9B9B-4FE1-9AA1-8B9936ACED0F Q38180320-F545F546-5C10-4350-89AE-0BAF6E02966B Q38261966-81D45100-78C8-4A31-9E9A-FDA5BD90882A Q38958563-83D4E9F1-1B39-4525-98AA-BB5912F10312 Q41047711-BE6E4685-B133-471F-BBE5-CF707509B4FF Q41612878-79E520DF-C911-4798-8E23-30D3507140EA Q41880464-0B519FEC-988B-453A-A391-107CC9BC606A Q41953800-22A77A71-3C25-4337-AFF8-DAF2AFE1D1D5 Q42414300-21D9423A-1DAC-462A-8CAB-4BAFAB8E9043 Q44421418-6ABA6018-CB60-4144-BB8C-3741A14664A2 Q47138387-8424CC9E-871E-421F-8B45-1A4323BD7DE5

P2860

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

http://www.wikidata.org/entity/Q30887474

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hypoxia-inducible factor-1alph ...... lls of breast cancer patients.

@ast

Hypoxia-inducible factor-1alph ...... lls of breast cancer patients.

@en

type

label

Hypoxia-inducible factor-1alph ...... lls of breast cancer patients.

@ast

Hypoxia-inducible factor-1alph ...... lls of breast cancer patients.

@en

prefLabel

Hypoxia-inducible factor-1alph ...... lls of breast cancer patients.

@ast

Hypoxia-inducible factor-1alph ...... lls of breast cancer patients.

@en

P1433

Q30887474-34C02596-B8FB-47F5-AE94-E5F4F7CAB1E8

P1476

Q30887474-6C88A829-B44F-4CF7-BD10-F304F9B9AF17

P2093

Q30887474-23E52D06-B210-464A-8CE0-2E3966F2AA63

Q30887474-379AD7B0-2A58-4557-8FEF-DAA43C872C22

Q30887474-526196A9-019A-49FB-A893-86EA57C683AF

Q30887474-59130F95-6222-4555-8119-EA22126E4347

Q30887474-BE743F40-0230-4E1E-874E-64C4005F729E

Q30887474-D907515F-9CB4-4731-B2E7-BCA9938E7A1C

Q30887474-ECCCD9DC-E00D-4027-AE1C-24DB16D1C8CE

Q30887474-F984F6D5-BF56-4DFC-B2B1-E6E7B14B967F

P2860

Q30887474-0F85F6CD-58CA-4752-B446-CFCAB96B4827

Q30887474-19D3C147-AB9B-47CF-ACCE-2AAEE2BA8A1C

Q30887474-1E1B75EA-B847-4FC6-A4F8-A2E3FCC4054E

Q30887474-1FB37C7E-0527-4000-8E94-E286CB6B5CAC

Q30887474-1FEB5440-6F14-4AEC-8A00-6C6353C76505

Q30887474-27991569-92C0-40DE-B82A-432AB4509C46

Q30887474-27E7F746-B175-4977-AF63-5EAAB3F0B734

Q30887474-2AFE9DC8-DDC7-4ECD-988A-1F31B4A1BCFF

Q30887474-3721D57D-967D-44A0-9CFF-FBC2A0AB7554

Q30887474-37E14E62-8FC1-4774-8086-9FAF52D835E0

P2888

Q30887474-FD0A5E2E-418C-442A-80F4-168F8D796CC1

P304

Q30887474-15B439FE-686C-4F4A-BDC5-1575660F353D

P31

Q30887474-DA0FAD82-985E-4535-9276-F5AF7A6B5C3C

P356

Q30887474-CB865F56-5940-410C-B150-EE901EC78D0E

P433

Q30887474-EF82B29C-C42B-4BCE-AD87-F57E8152B005

P478

Q30887474-8E7978AB-00F6-421C-BFAA-7532E53FBD4C

P50

Q30887474-CB0BEB0A-59AB-4812-A6F9-2CC5E35101D2

P577

Q30887474-48F835AE-6E38-4B55-8424-E36E3E09F9C1

P5875

Q30887474-156BDBBF-7909-4A80-A179-B69D53CA7DF0

P6179

Q30887474-A44D2921-DF37-4509-AFA5-9B0617EF58FA

P698

Q30887474-8F403D0F-F885-40B1-8C46-74C010F6EEA2

P921

Q30887474-A08DB45C-BDA6-4812-84DA-93FFD031F219

Q30887474-B906A2CF-E7F8-482D-A3A6-E5DB68066D6E

P932

Q30887474-4F14E23D-CA83-442E-9601-F697A46C79EE

P356

P1433

Breast Cancer Research

P1476

Hypoxia-inducible factor-1alph ...... ells of breast cancer patients

@en

P2093

Areti Strati

http://www.w3.org/2001/XMLSchema#string

Dimitris Mavroudis

http://www.w3.org/2001/XMLSchema#string

Evi S Lianidou

http://www.w3.org/2001/XMLSchema#string

Harris Markomanolaki

http://www.w3.org/2001/XMLSchema#string

Maria A Papadaki

http://www.w3.org/2001/XMLSchema#string

Sofia Agelaki

http://www.w3.org/2001/XMLSchema#string

Vassilis Georgoulias

http://www.w3.org/2001/XMLSchema#string

Vicky Giannoukaraki

http://www.w3.org/2001/XMLSchema#string

P2860

Integrin-regulated FAK-Src signaling in normal and cancer cells

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

Vascular endothelial growth factor is a secreted angiogenic mitogen

Hypoxia--a key regulatory factor in tumour growth

Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.

Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells

Detection and clinical importance of micrometastatic disease.

Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.

P2888

P304

R84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2452

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Galatea Kallergi

P577

2009-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38095492

http://www.w3.org/2001/XMLSchema#string

P6179

1027486239

http://www.w3.org/2001/XMLSchema#string

P698

19919679

http://www.w3.org/2001/XMLSchema#string

P921

P932

2815547

http://www.w3.org/2001/XMLSchema#string